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To explore the role of chronic inflammation inherent to autoimmune diseases in the 
development of subclinical atherosclerosis and arterial stiffness, this study recruited two 
population-based samples of individuals with and without autoimmune disease (ratio 
1:5) matched by age, sex, and education level and with a longstanding (≥6 years) 
diagnosis of autoimmune disease. Common carotid intima media thickness (IMT) and 
arterial distensibility and compliance were assessed with carotid ultrasound. 
Multivariable linear and logistic regression models were adjusted for 10-year 
cardiovascular risk. In total, 546 individuals with and without autoimmune diseases (91 
and 455, respectively) were included. Mean age was 66 years (standard deviation 12), 
and 240 (43.9%) were women. Arterial stiffness did not differ according to presence of 
autoimmune diseases. In men, the diagnosis of autoimmune diseases significantly 
increased common carotid IMT [beta-coefficient (95% confidence interval): 0.058 
(0.009; 0.108); p-value=0.022] and the percentage having IMT ≥ percentile 75 [1.012 
(0.145; 1.880); p-value=0.022]. Women without autoimmune disease were more likely 
to have IMT ≥ percentile 75 [-2.181 (-4.214; -0.149); p-value=0.035] but analysis of 
IMT as a continuous variable did not yield significant results. In conclusion, subclinical 
carotid atherosclerosis, but not arterial stiffness, was higher in men with autoimmune 
diseases. Women did not show significant differences in any of these carotid features. 
Sex was an effect modifier in the association between common carotid IMT values and 
the diagnosis of autoimmune diseases. 
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Cardiovascular diseases are the main cause of death in western countries [1]. Their 
common basis is adverse structural and functional change within vascular walls, 
specifically atherosclerosis and arteriosclerosis – which tend to co-exist, causing 
progressive, diffuse, and age-related deterioration in all vascular beds [2]. 
Atherosclerosis is a chronic inflammatory and degenerative process that mainly occurs 
in large and medium-sized arteries morphologically characterized by asymmetric focal 
thickenings of the innermost layer of the artery, the intima [3]. Arteriosclerosis is 
degenerative stiffness of the arterial beds, defined as the reduced capability of an artery 
to expand and contract in response to pressure changes.  
The premature arterial degeneration observed in individuals with autoimmune 
disease may be a consequence of the chronic inflammation inherent to these disorders 
[4, 5, 6, 7]. Additionally, the cardiovascular risk profile, significantly worse in 
individuals with autoimmune diseases than in the general population [8], is directly 
associated with both carotid IMT and arterial stiffness values [9, 10]. Most studies that 
have addressed subclinical atherosclerosis included participants with autoimmune 
disease, usually recruited in-hospital; therefore, they are more likely to have advanced 
disease stages. This somewhat limits the generalization of study results.  
The objective of this study was to assess the prevalence of subclinical 
atherosclerosis (common carotid IMT) and arterial stiffness (distensibility and 
compliance) in individuals with longstanding (≥6 years) diagnosis of autoimmune 
disorders (inflammatory polyarthropathies, systemic connective tissue disorders, 





We carried out a cross-sectional analysis of a population-based sample recruited in 
Girona province (northeastern Spain) in 2005 in the context of the REGICOR (REgistre 
Gironí del COR, or Girona Heart Registry) study. Recruitment details have been 
described elsewhere [11]. Briefly, participants were randomly selected from the city of 
Girona (approximately 70,000 inhabitants) and three surrounding rural towns. Inclusion 
criteria required that participants be free of terminal disease, not institutionalized, aged 
45 or older at baseline. and residents of the referral area for at least six months/year 
(reflecting the stable seasonal presence of a large number of retirees). Participants were 
contacted by a letter informing them of the aims of the study and the tests to be 
performed. If willing to participate, they were asked to fast for at least 10 hours before 
their appointment at the health examination site. The participation rate was 73.8%. 
Participants were reexamined in 2010 and carotid IMT measures were taken [9]. All 
participants were duly informed and provided their written consent to participate in the 
study and the results of the examination were sent to each of them. The study protocol 
was approved by the local ethics committee (CEIm-PSMAR 2008/3046/I; 2016/7075/I). 
From these data, we selected a sample of exposed individuals diagnosed with 
autoimmune disease (i.e., inflammatory polyarthropathies, systemic connective tissue 
disorders, inflammatory bowel diseases, spondylopathies) and non-exposed individuals 








The diagnosis of autoimmune diseases was obtained from the System for the 
Development of Research in Primary Care (SIDIAP) database, which includes the 
anonymized electronic medical records of approximately 80% of the Catalan population 
[12]. These diagnoses were coded according to the International Classification of 
Diseases 10th edition (ICD-10) and divided in four groups: (1) inflammatory bowel 
diseases, (2) inflammatory polyarthropathies, (3) systemic connective tissue disorders, 
and (4) spondylopathies (Supplementary Table 1).  
 
Measurements 
Examinations were performed by a team of trained nurses and interviewers. A precision 
scale of easy calibration was used for weight and height measurement with participants 
in underwear and barefoot. Body mass index was determined as weight divided by 
squared height (kg/m2). Blood pressure was measured with a periodically calibrated 
sphygmomanometer (OMRON 711). A cuff adapted to the upper arm perimeter (young, 
adult, obese) was selected for each participant. Measurements were performed in a 
seated position after a 5-minute rest. Two measurements were taken and the lower value 
was recorded for the study. Standardized questionnaires were used to collect 
sociodemographic and lifestyle variables, along with previous history and treatments for 
diabetes, hypertension and hypercholesterolemia. Current smoking was defined as 
actively smoking within the preceding year. Blood was withdrawn after 10-14 h of 
fasting. Total and high-density lipoprotein (HDL) cholesterol concentrations were 
determined by direct methodology (Roche Diagnostics, Basel, Switzerland). Low-
density lipoprotein (LDL) cholesterol was calculated by the Friedewald equation 
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whenever triglycerides were <3.4mmol/l (300 mg/dl). Coronary risk in participants aged 
35-74 years was calculated by the REGICOR function adapted from the original 
Framingham function and validated for the Spanish population [13]. 
 
Carotid ultrasound 
Two trained sonographers performed the carotid ultrasound examinations at follow-up 
reexamination. An Acuson XP128 ultrasound machine equipped with an L75-10 MHz 
transducer and extended frequency software was used (Acuson-Siemens, 
Mountainview, California, United States). The image analyses were performed by 
expert trained readers with validated software (eTRACK) used in previous studies [14]. 
 
Common carotid intima media thickness 
B-mode ultrasound images of the common carotid artery segment were obtained in 
DICOM format with a resolution of 0.043 mm/p. Image files were recorded and sent to 
the Academic Vascular Image Centre in Amsterdam (AVICA) for analysis (gold-
standard). Measurements were made in a 1-cm segment in the distal common carotid 
artery (1 cm proximal to the dilation of the carotid bulb) of both right and left arteries. 
Measurements were made every 1 mm in the 1-cm segment, from which the mean 
values were calculated. Repeatability analysis was performed in 42 participants who 
were examined by 3 sonographers at 2 different visits. The intraclass correlation 
coefficients between sonographers and within each sonographer’s results for the mean 
common carotid artery were 0.83 and 0.85, respectively. The coefficient of variation 




A fully automatic deep-learning method able to properly localize the intima media 
region and then estimate the IMT was used (Supplementary Table 2). This machine-
learning procedure is based on convolutional neural networks and was validated using 
the IMT estimates performed in AVICA as the gold-standard [15]. Left and right 
common carotid IMT were obtained for each participant and the mean considered in the 
analysis. As a proxy of atherosclerotic plaque presence, men and women with common 
carotid IMT values ≥ percentile 75 of the population reference values were identified [9, 
16].   
 
Arterial stiffness 
We obtained the arterial distensibility coefficient and compliance coefficient, defined as 
the relative and absolute change, respectively, in cross-sectional area per unit of 
pressure. During the carotid ultrasound scan, the anterior and posterior walls of the 
distal right and left common carotid arteries were visualized in B-mode. To obtain the 
M-mode anterior wall intima-lumen and posterior wall lumen-intima tracings, the 
sonographer switched from full B-mode to a 1/3 B-mode 2/3 M-mode image of the 
distal common carotid. The 1/3 B-mode image guides the M-mode. The movement of 
the arterial walls on the 2/3 M-mode image shows waveforms with the double-line 
patterns of the arterial walls over time. The eTRACK software traces the wave-forms of 
the leading edges of anterior wall intima-lumen and posterior wall lumen-intima 
interfaces. If the contours of both walls are identified for at least 2 heartbeats, the 
software can calculate lumen diameter parameters and heart rates. Based on this 
information, other outcome parameters (e.g., distensibility and compliance coefficient) 
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were derived using the equations from the Task Force III Summary of Clinical 
Applications of Arterial Stiffness [17]. 
 
Statistical analysis 
Continuous variables were summarized as mean (standard deviation), or median 
[interquartile range] when their distribution departed from normal, and categorical 
variables as proportions. Effect modification of the relationship of diagnosed 
autoimmune diseases with subclinical atherosclerosis and arterial stiffness was 
anticipated a priori [18, 19] and tested with the -2 loglikelihood test of nested models 
with and without interaction terms. The sample was stratified by sex. 
Chi-square, Student-t, and Mann-Whitney U tests were used as appropriate to 
compare the prevalence of cardiovascular risk factors at baseline in individuals with and 
without autoimmune diseases and to ascertain arterial distensibility and compliance and 
the distribution of cardiovascular risk factors by terciles of common carotid IMT values. 
We fitted linear regression models for men and women, adjusted for the cardiovascular 
risk factors that significantly modified arterial distensibility and compliance and 
common carotid IMT. Additionally, a logistic regression was fitted in the case of 
individuals with common carotid IMT value ≥ percentile 75. To assess the effect of 
vasodilation factors and anti-inflammatory drugs, we performed sensitivity analysis 
excluding current smokers and a multivariable analysis further adjusted for calcium-
channel blockers and for anti-inflammatory drugs. 
Statistical analysis was done with the R Statistical Package (R Foundation for 






We included 91 individuals with autoimmune disease and 455 without this diagnosis 
(n=546). The most common group of autoimmune diseases was inflammatory 
polyarthropathies in both men (74.0%) and women (51.2%). Systemic connective tissue 
disorders in women (22.0%) and inflammatory bowel diseases in men (14.0%) were the 
second most prevalent group of diseases. Men with autoimmune diseases had higher 
prevalence of hypertension and diabetes and higher LDL cholesterol and 10-year 
cardiovascular risk values, compared to those without such diseases. In women, the 
cardiovascular risk profile did not differ according to the presence of these diseases 
(Table 1). Biomarkers of subclinical atherosclerosis and arterial stiffness were similar in 
individuals with and without autoimmune diseases, except for IMT ≥ percentile 75, 
which was significantly lower in women with an autoimmune diagnosis (Table 2). 
The 10-year cardiovascular risk was associated, in all instances, with the tercile of 
common carotid IMT and the distensibility and compliance coefficients (Table 3, 4 and 
5). The risk score used to adjust the multivariate models integrates 8 variables (sex, age, 
systolic and diastolic blood pressure, total and HDL cholesterol, diabetes, and smoking 
habit), most of them significantly correlated with the terciles of subclinical 
atherosclerosis and arterial stiffness.   
The models adjusted for 10-year cardiovascular risk showed that a diagnosis of 
autoimmune disease in men significantly increased the mean common carotid IMT 
values [beta-coefficient (95% confidence interval): 0.058 (0.009; 0.108); p-
value=0.022]. This association was not significant in women [-0.023 (-0.071; 0.025); p-
value=0.353]. In addition, the prevalence of common carotid IMT ≥ percentile 75 was 
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higher in men with autoimmune diseases than in those without [1.012 (0.145; 1.880); p-
value=0.022]; in contrast, women without autoimmune disease were more likely to have 
IMT ≥ percentile 75 [-2.181 (-4.214; -0.149); p-value=0.035]. No significant differences 
were found for arterial stiffness biomarkers (Table 6). Finally, no differences were 
observed in the sensitivity analysis when current smokers were excluded 
(Supplementary Table 3) or when further adjusted for use of calcium-channel blockers 
or anti-inflammatory drugs (Supplementary Tables 4 and 5).  
 
Discussion 
The diagnosis of autoimmune diseases was a risk factor for subclinical atherosclerosis 
in men from our cohorts of individuals with and without autoimmune diseases matched 
by age, sex, and education level. Sex acted as an effects modifier in this association: the 
difference was not significant in women. In contrast, arterial stiffness, as measured with 
the coefficients of distensibility and compliance, was not increased in individuals with 
autoimmune diseases.  
 
Autoimmune diseases as a risk factor for subclinical atherosclerosis 
Previous studies have shown higher prevalence of subclinical atherosclerosis and 
clinically overt cardiovascular disease in individuals diagnosed with autoimmune 
disorders [4, 5, 20, 21, 22, 23]. Thus, immune-mediated inflammation is likely to play a 
pivotal role in the pathogenesis of atherosclerosis, being involved in endothelial 
dysfunction, plaque rupture and thrombosis [7, 24]. Specifically for inflammatory joint 
diseases, the central event of synovitis and autoimmune atherosclerosis is the 
accumulation of inflammatory cells and mediators in the synovial tissue and vessel wall, 
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respectively [25]. Therefore, the most recent European League Against Rheumatism 
guideline promotes a proactive management of cardiovascular risk in individuals with 
inflammatory polyarthritis and spondylopathies. The primary preventive and therapeutic 
goal is to control the underlying autoimmune-inflammatory process [26]. These 
recommendations have also been proposed for individuals with systemic lupus 
erythematosus [27] but could likely be extended to individuals with any systemic 
connective tissue disorder.  
 
Participant sex modifies the effect of autoimmune diseases on IMT 
The magnitude of the effect of the diagnosis of autoimmune diseases on subclinical 
atherosclerosis was higher in men than in women. Indeed, the stratified analysis showed 
that the effect of exposure to autoimmune diseases on common carotid IMT values 
remained significant only in men. On the one hand, men participating in our study were 
older and had worse cardiovascular risk profile than the women, which could explain 
the sex-related differences observed in common carotid IMT. This observation concurs 
with previous studies developed in Spain and in other countries [9, 18, 28, 29]. On the 
other hand, Freirix et al. described the absence of intima media thickening in women 
with systemic lupus erythematosus or systemic sclerosis; thus, definite atherosclerosis 
(plaque detection) occurred frequently without signs of subclinical atherosclerosis 
(increased IMT) in both autoimmune diseases [30]. This observation could help to 
explain the nonsignificant results found in our study, despite the increased 
cardiovascular risk traditionally observed in women with autoimmune disease [31].  
 
Arterial stiffness and systemic inflammation 
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Several studies in the general population revealed an association between inflammatory 
biomarkers and arterial stiffness [6, 32, 33, 34]. However, our cross-sectional study did 
not show significant differences between individuals with and without autoimmune 
diseases. First, individuals having autoimmune diseases presented with a wide range of 
severity because they were selected randomly on a population basis [11]. Second, most 
previous studies used the carotid-femoral pulse wave velocity, the gold standard for 
assessing regional arterial stiffness, a value usually obtained by tonometry or 
mechanotransducers [32, 33, 34]. Since we performed an ultrasound analysis, 
commonly used to assess local mechanical properties of arterial walls, the measures 
considered to assess arterial stiffness were carotid distensibility and compliance [35]. 
Nevertheless, the adjusted coefficients pointed out higher resistance to vascular 




Our study has several limitations. First, the added value of common carotid IMT for 
cardiovascular risk prediction beyond classical risk factors remains controversial [36, 
37]. In addition, the reproducibility of IMT measures is a controversial issue [38] that 
we have minimized with a previously validated machine-learning procedure [39]. On 
the other hand, the use of carotid ultrasound revealed the arterial stiffness of the carotid 
wall but did not allow measurement of carotid-femoral pulse wave velocity, the gold 
standard for assessing this variable. Second, it was beyond the objectives of our study to 
measure blood biomarkers (e.g., systemic inflammation, endothelial dysfunction, 
prothrombotic state) to explore the potential mechanisms that may accelerate 
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atherosclerosis in patients with autoimmune disease [40]. To avoid misclassification 
bias, we used medical diagnosis of autoimmune disease as a robust marker of 
inflammatory status. Although these diagnoses were extracted from routinely collected 
data that may reflect underreporting, the SIDIAP database has been validated for 
research in cardiovascular epidemiology [41] and rheumatic diseases [42]. Indeed, the 
prevalence of autoimmune diseases found in SIDIAP concurred with previous studies in 
other datasets [43, 44, 45]. Third, the low prevalence of autoimmune diseases was 
reflected in our population-based study. Nevertheless, we obtained consistent results 
from our multivariable analysis adjusted for 10-year cardiovascular risk, a composite 
score with variables that showed significant differences in the bivariate analysis. Indeed, 
the sensitivity analysis yielded similar results when adjusted by drugs with anti-
inflammatory or vasodilation effect (e.g. calcium-channel blockers) and excluding 
current smokers. In addition, cigarette smoking has shown to attenuate the endothelium-
dependent vasodilation [46]. A priori, this effect might be similar in smokers with and 
without autoimmune diseases because the sample selection was not based on this 
variable. Finally, to avoid a selection bias, our cohorts were matched by age, sex and 
education level and did not present significant differences in the 10-year cardiovascular 
risk. Although this approach may hamper the population representativeness of the 
studies, the associations found between cardiovascular risk factors and common carotid 
intima-media thickness concur with previous studies [9, 29].  
 
Conclusion 
Subclinical carotid atherosclerosis, but not stiffness, was higher in men with 
autoimmune diseases than in the general population. No significant differences were 
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found in women with and without autoimmune diseases in these carotid features. Sex 
was an effect modifier in the association between the diagnosis of autoimmune diseases 
and the common carotid IMT values. 
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Table 1. Characteristics of the whole sample and stratified by sex 
 Autoimmune diseases 













Age (years), mean (SD) 67 (12) 68 (12) 0.813 64 (12) 64 
(12) 
0.955 
Education level, n (%)   0.986   0.949 
































 -- 21 
(51.2) 
 
Systemic connective tissue 
disorders 
-- 3 (6.0)  -- 10 
(24.4) 
 
Inflammatory bowel diseases -- 7 
(14.0) 
 -- 9 
(22.0) 
 
Spondylopathies -- 3 (6.0)  -- 1 (2.4)  

























4 (9.8)  




















Diastolic blood pressure 
(mmHg), mean (SD) 
77 (10) 78 (11) 0.546 73 (9) 75 (9) 0.229 


















Calcium channel blockers 





0.121 4 (2.0) 1 (2.4) 0.999 











HDL cholesterol (mg/dl), mean 
(SD) 
48 (11) 46 (11) 0.135 57 (11) 58 
(10) 
0.540 











Triglycerides (mg/dl), median 
[IQR] 
















































HDL: High-density lipoprotein. IQR: interquartile range. LDL: Low-density 




Table 2. Subclinical atherosclerosis and arterial stiffness biomarkers by 
diagnosis of autoimmune diseases 
 Autoimmune disease 











































































Table 3. Characteristics of the sample by terciles of common carotid intima-media thickness 





























Age (years), mean (SD) 60 (13) 68 (11) 74 (9) <0.001 55 (11) 66 (10) 72 (9) <0.001 
Education level, n (%)    0.031    <0.001 
No studies or primary school 59 (57.8) 66 (64.7) 80 (78.4)  30 (37.5) 48 (60.0) 56 (70.0)  
Secondary school 23 (22.5) 20 (19.6) 14 (13.7)  21 (26.2) 25 (31.2) 22 (27.5)  
University 20 (19.6) 16 (15.7) 8 (7.8)  29 (36.2) 7 (8.8) 2 (2.5)  
Autoimmune diseases 13 (12.7) 21 (20.6) 16 (15.7) 0.310 14 (17.5) 18 (22.5) 9 (11.2) 0.166 
Smoker, n (%) 49 (49.0) 57 (57.0) 57 (55.9) 0.469 19 (24.4) 8 (10.1) 6 (7.7) 0.005 
Body mass index, mean (SD) 27.7 (3.6) 27.4 (3.9) 27.6 (3.2) 0.788 25.6 (4.7) 27.1 (4.5) 27.7 
(4.0) 
0.010 
Systolic blood pressure 
(mmHg), mean (SD) 
132 (17) 139 (19) 145 (23) <0.001 117 (16) 130 (19) 138 (19) <0.001 
Diastolic blood pressure 
(mmHg), mean (SD) 
78 (10) 79 (9) 75 (11) 0.009 73 (9) 75 (10) 74 (8) 0.300 
Hypertension, n (%) 45 (44.6) 58 (58.0) 72 (72.0) <0.001 23 (29.9) 34 (43.0) 51 (64.6) <0.001 
Anti-inflammatory treatment, 
n (%) 
5 (4.9) 7 (6.9) 3 (2.9) 0.431 7 (8.8) 15 (18.8) 15 (18.8) 0.129 
Calcium channel blockers 
treatment, n (%) 
8 (7.8) 12 (11.8) 13 (12.7) 0.490 2 (2.5) 2 (2.5) 1 (1.3) 0.999 
Total cholesterol (mg/dl), 
mean (SD) 
201 (39) 189 (37) 187 (31) 0.008 202 (39) 214 (31) 219 (37) 0.012 
HDL cholesterol (mg/dl), 
mean (SD) 
47 (10) 50 (11) 46 (11) 0.037 57 (10) 58 (12) 56 (10) 0.700 
LDL cholesterol (mg/dl), 
mean (SD) 
132 (34) 118 (32) 118 (28) 0.003 128 (33) 136 (27) 141 (31) 0.028 






























Diabetes, n (%) 19 (19.2) 26 (27.1) 41 (41.4) 0.002 9 (11.7) 13 (16.7) 16 (20.8) 0.312 
10-year cardiovascular risk 



















Table 4. Characteristics of the sample by terciles of arterial distensibility 





























Age (years), mean (SD) 73 (10) 68 (11) 59 (13) <0.001 72 (9) 67 (10) 54 (10) <0.001 
Education level, n (%)    0.069    <0.001 
No studies or primary school 73 (74.5) 59 (60.2) 63 (64.9)  61 (76.2) 47 (58.8) 26 (32.9)  
Secondary school 18 (18.4) 18 (18.4) 20 (20.6)  14 (17.5) 29 (36.2) 24 (30.4)  
University 7 (7.1) 21 (21.4) 14 (14.4)  5 (6.2) 4 (5.0) 29 (36.7)  
Autoimmune diseases 17 (17.3) 14 (14.3) 17 (17.5) 0.789 15 (18.8) 13 (16.2) 13 (16.5) 0.897 
Smoker, n (%) 52 (53.6) 54 (55.7) 47 (49.0) 0.633 5 (6.4) 10 (12.7) 18 (23.4) 0.009 
Body mass index, mean (SD) 28.2 (4.0) 27.5 (3.4) 26.9 (3.1) 0.044 28.2 (4.1) 27.4 (4.4) 24.9 (4.4) <0.001 
Systolic blood pressure 
(mmHg), mean (SD) 
149 (23) 137 (14) 128 (16) <0.001 143 (18) 129 (15) 112 (13) <0.001 
Diastolic blood pressure 
(mmHg), mean (SD) 
77 (11) 79 (9) 77 (10) 0.283 76 (10) 75 (8) 70 (8) <0.001 
Hypertension, n (%) 67 (69.8) 56 (57.7) 42 (44.2) 0.002 59 (76.6) 36 (45.6) 12 (15.4) <0.001 
Anti-inflammatory treatment, 
n (%)  
4 (4.1) 6 (6.1) 4 (4.1) 0.834 18 (22.5) 13 (16.2) 6 (7.6) 0.033 
Calcium channel blockers 
treatment, n (%) 
19 (19.4) 4 (4.1) 6 (6.2) 0.001 4 (5.0) 1 (1.2) 0 (0.0) 0.131 
Total cholesterol (mg/dl), 
mean (SD) 
186 (33) 188 (37) 200 (38) 0.016 211 (32) 218 (37) 205 (40) 0.073 
HDL cholesterol (mg/dl), 
mean (SD) 
47 (11) 48 (12) 48 (10) 0.842 55 (12) 57 (11) 58 (10) 0.326 
LDL cholesterol (mg/dl), 
mean (SD) 
117 (30) 118 (32) 131 (34) 0.005 133 (26) 142 (31) 130 (34) 0.041 






























Diabetes, n (%) 35 (36.8) 29 (30.9) 17 (18.5) 0.019 23 (30.7) 10 (12.8) 5 (6.4) <0.001 
10-year cardiovascular risk 














IQR: interquartile range; SD: standard deviation 
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Table 5. Characteristics of the sample by terciles of arterial compliance 





























Age (years), mean (SD) 70 (11) 68 (12) 62 (13) <0.001 69 (11) 65 (11) 58 (12) <0.001 
Education level, n (%)    0.853    <0.001 
No studies or primary school 68 (69.4) 63 (64.3) 64 (66.0)  55 (67.9) 53 (65.4) 26 (33.8)  
Secondary school 16 (16.3) 22 (22.4) 18 (18.6)  23 (28.4) 19 (23.5) 25 (32.5)  
University 14 (14.3) 13 (13.3) 15 (15.5)  3 (3.7) 9 (11.1) 26 (33.8)  
Autoimmune diseases 16 (16.3) 16 (16.3) 16 (16.5) 0.999 15 (18.5) 13 (16.0) 13 (16.9) 0.914 
Smoker, n (%) 51 (52.6) 59 (60.8) 43 (44.8) 0.083 7 (8.9) 9 (11.2) 17 (22.7) 0.032 
Body mass index, mean (SD) 27.4 (4.0) 28.2 (3.6) 27.0 (3.0) 0.064 27.1 (4.2) 27.1 (4.7) 26.1 (4.4) 0.265 
Systolic blood pressure 
(mmHg), mean (SD) 
147 (22) 138 (16) 131 (18) <0.001 139 (21) 129 (16) 117 (16) <0.001 
Diastolic blood pressure 
(mmHg), mean (SD) 
78 (11) 77 (10) 77 (10) 0.429 76 (9) 74 (8) 72 (9) 0.011 
Hypertension, n (%) 64 (67.4) 54 (55.1) 47 (49.5) 0.039 50 (64.1) 35 (43.8) 22 (28.9) <0.001 
Anti-inflammatory treatment, 
n (%) 
5 (5.1) 6 (6.1) 3 (3.1) 0.698 13 (16.0) 17 (21.0) 7 (9.1) 0.116 
Calcium channel blockers 
treatment, n (%) 
12 (12.2) 10 (10.2) 7 (7.2) 0.497 3 (3.7) 1 (1.2) 1 (1.3) 0.624 
Total cholesterol (mg/dl), 
mean (SD) 
193 (38) 189 (36) 193 (36) 0.683 215 (35) 211 (34) 209 (41) 0.580 
HDL cholesterol (mg/dl), 
mean (SD) 
49 (12) 48 (11) 47 (10) 0.627 56 (12) 57 (11) 58 (10) 0.612 
LDL cholesterol (mg/dl), 
mean (SD) 
123 (34) 119 (31) 125 (33) 0.369 137 (29) 135 (30) 134 (34) 0.841 






























Diabetes, n (%) 30 (32.6) 30 (30.9) 21 (22.8) 0.292 21 (27.3) 12 (15.4) 5 (6.6) 0.002 
10-year cardiovascular risk 


















Table 6. Subclinical atherosclerosis biomarkers by diagnosis of autoimmune diseases 
 Autoimmune diseases 
 Men Women 
















































0.637 0.008 -0.074; 
0.091 
0.844 
IMT: Intima-media thickness. SD: standard deviation. All models have been 
adjusted for 10-year cardiovascular risk. 
*Linear regression model. †Logistic regression model.  
 
 
